Compare DAL & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAL | GEHC |
|---|---|---|
| Founded | 1924 | 1892 |
| Country | United States | United States |
| Employees | 78400 | N/A |
| Industry | Air Freight/Delivery Services | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.2B | 32.1B |
| IPO Year | 2004 | 2022 |
| Metric | DAL | GEHC |
|---|---|---|
| Price | $70.11 | $72.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | $79.26 | ★ $88.77 |
| AVG Volume (30 Days) | ★ 11.4M | 2.9M |
| Earning Date | 04-08-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.07% | 0.19% |
| EPS Growth | ★ 43.71 | 4.84 |
| EPS | N/A | ★ 4.55 |
| Revenue | ★ $41,244,000,000.00 | $20,625,000,000.00 |
| Revenue This Year | $3.47 | $7.12 |
| Revenue Next Year | $3.97 | $4.45 |
| P/E Ratio | ★ N/A | $15.86 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $39.94 | $64.77 |
| 52 Week High | $76.39 | $89.77 |
| Indicator | DAL | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 46.06 |
| Support Level | $68.50 | $69.59 |
| Resistance Level | $71.95 | $74.83 |
| Average True Range (ATR) | 2.63 | 1.65 |
| MACD | 0.26 | 0.30 |
| Stochastic Oscillator | 53.15 | 45.29 |
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).